ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 67 filers reported holding ENZON PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $13,000 | +18.2% | 49,119 | 0.0% | 0.00% | – |
Q1 2019 | $11,000 | -42.1% | 49,119 | -36.3% | 0.00% | – |
Q4 2018 | $19,000 | +18.8% | 77,141 | +18.8% | 0.00% | – |
Q3 2018 | $16,000 | +60.0% | 64,923 | +63.6% | 0.00% | – |
Q2 2018 | $10,000 | 0.0% | 39,691 | 0.0% | 0.00% | – |
Q1 2018 | $10,000 | -9.1% | 39,691 | 0.0% | 0.00% | – |
Q4 2017 | $11,000 | +10.0% | 39,691 | -5.3% | 0.00% | – |
Q3 2017 | $10,000 | -47.4% | 41,925 | -18.2% | 0.00% | – |
Q2 2017 | $19,000 | +58.3% | 51,280 | 0.0% | 0.00% | – |
Q1 2017 | $12,000 | -36.8% | 51,280 | 0.0% | 0.00% | – |
Q4 2016 | $19,000 | 0.0% | 51,280 | 0.0% | 0.00% | – |
Q3 2016 | $19,000 | -87.8% | 51,280 | -66.2% | 0.00% | -100.0% |
Q1 2014 | $156,000 | -11.4% | 151,905 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $176,000 | -31.8% | 151,905 | -1.2% | 0.00% | 0.0% |
Q3 2013 | $258,000 | -26.1% | 153,805 | -12.4% | 0.00% | -50.0% |
Q2 2013 | $349,000 | – | 175,667 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBERT MANAGEMENT CORP | 351,700 | $703,000 | 0.42% |
Baupost Group | 7,691,453 | $15,383,000 | 0.38% |
PRICE MICHAEL F | 748,200 | $1,496,000 | 0.20% |
Rotella Capital Management, Inc. | 25,542 | $51,000 | 0.16% |
Gruss Capital Management LP | 517,000 | $1,034,000 | 0.11% |
ALGERT GLOBAL LLC | 124,891 | $250,000 | 0.08% |
Spark Investment Management LLC | 139,800 | $267,000 | 0.07% |
Icahn Capital | 5,904,863 | $11,810,000 | 0.06% |
NWAM LLC | 49,326 | $99,000 | 0.05% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 131,389 | $262,000 | 0.03% |